Why is Venmax Drugs falling/rising?

As of 08-Sep, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 24.00, which reflects a decrease of 0.7 or 2.83%. The stock has been underperforming significantly, having fallen consecutively for the last eight days, resulting in a total decline of 30.64% during this period. Additionally, the stock's performance over the past week shows a substantial drop of 20.79%, while it has also underperformed its sector by 2.7% today. The delivery volume has decreased dramatically, with a drop of 83.87% compared to the five-day average, indicating a lack of investor participation. The stock is currently trading above its 200-day moving average but below its shorter-term moving averages, suggesting mixed signals regarding its price momentum.
In the broader market context, the Sensex has shown a slight increase of 0.53% over the past week, contrasting sharply with Venmax's significant decline. While the stock has a year-to-date return of 33.04%, which is positive compared to the Sensex's 3.39%, the recent performance indicates a troubling trend. The stock's inability to keep pace with the benchmark in the short term, combined with the falling investor participation and consecutive price drops, suggests that market sentiment is currently negative towards Venmax Drugs.